HOME
About
Technical
Media
Careers
Contact us
语言

2019-01-09

OMNI Pharma is focusing on respiratory drug delivery technology and was nominated for “The Top 100 potential Enterprises of STAR Market”

2018-12-30

OMNI Pharma was awarded as “2018 Zhangjiang Top 100 Enterprises”

2018-12-18

OMNI Pharma was awarded as “2018 Chinese Future Healthcare Top 100 Enterprises”

2017-11-17

OMNI Pharma Completed C Round of $260 Million Financing: Developing High Quality Respiratory Formulations

2016-10-25

OMNI Pharma’s metered dose inhaler and dry powder inhaler participated in the Reform of Shanghai Drug Listing Permit Holder System
上一页
下一页

备案号：沪ICP备12031398号-1